Amy Raskopf | Head of Investor Relation |
Saundra Pelletier | CEO |
Jay File | Chief Financial Officer |
Russell Barrans | Chief Commercial Officer |
Kelly Culwell | Chief Medical Officer |
Louise Chen | Cantor |
Ram Selvaraju | H.C. Wainwright |
Ashley Ryu | RBC Capital Market |
Leland Gershell | Oppenheimer |
Ladies and gentlemen, thank you for standing by and welcome to the Evofem Biosciences Q1 2020 Financial Results Call. [Operator Instructions]
I'll now turn the call over to Amy Raskopf, Evofem Biosciences' Head of Investor Relations.
Thank you, and good morning, everyone.
If you haven't done so already, I encourage you to access the Q1 2020 presentation and the press release we issued earlier today, both of which are at evofem.com under the Investors tab.